Literature DB >> 9819564

Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.

H Toyoda1, B Formby.   

Abstract

The nonobese diabetic (NOD) mouse spontaneously develops an autoimmune diabetes that shares many immunogenetic features with human insulin-dependent diabetes mellitus (IDDM), type 1 diabetes. The mononuclear cell infiltrates in the islet, which results in the development of insulitis (a prerequisite step for the development of diabetes) are primarily composed of T cells. It is now well accepted that these T cells play important roles in initiating and propagating an autoimmune process, which in turn destroys insulin-producing islet beta cells in the pancreas. T cells are subdivided into CD4+ helper T cells and CD8+ cytotoxic T cells. CD4+ T cells are further subdivided into Th1 and Th2 cells based on profiles of cytokine production, and these two T-cell populations counterregulate each other. Because many autoimmune diseases are Th1 T-cell mediated, current studies have focused on manipulating the Th1/Th2 imbalance to suppress the autoimmune process in the NOD model. Furthermore, the incidence of disease is much higher in females than that in males, suggesting an involvement of sex-steroid hormones in the development of diabetes. Understanding insights of the mechanism of immune-mediated islet cell destruction and the interaction between the immune and the neuroendocrine system may, therefore, provide new therapeutic means of preventing this chronic debilitating disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9819564     DOI: 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.0.CO;2-K

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  11 in total

Review 1.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

2.  Spontaneous lymphocyt ic thyroiditis in interferon regulatory factor-1 deficient non-obese diabetic mice.

Authors:  S Hoshikawa; K Mori; J Tani; Z Jin; Y Nakagawa; J Satoh; S Ito; K Yoshida
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

3.  The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death.

Authors:  Qingguo Ruan; Ting Wang; Vasumathi Kameswaran; Qin Wei; Derek S Johnson; Franz Matschinsky; Weiyun Shi; Youhai H Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

4.  Analysis of mercury-induced immune activation in nonobese diabetic (NOD) mice.

Authors:  N Brenden; H Rabbani; M Abedi-Valugerdi
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

5.  Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.

Authors:  C J Fox; A D Paterson; S M Mortin-Toth; J S Danska
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

6.  Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice.

Authors:  Y Yamada; Y Okubo; A Shimada; Y Oikawa; S Yamada; S Narumi; K Matsushima; H Itoh
Journal:  Diabetologia       Date:  2012-04-11       Impact factor: 10.122

Review 7.  Parasitic helminths: new weapons against immunological disorders.

Authors:  Yoshio Osada; Tamotsu Kanazawa
Journal:  J Biomed Biotechnol       Date:  2010-02-10

8.  Induction of protective genes leads to islet survival and function.

Authors:  Hongjun Wang; Christiane Ferran; Chiara Attanasio; Fulvio Calise; Leo E Otterbein
Journal:  J Transplant       Date:  2011-12-14

9.  Catenarin Prevents Type 1 Diabetes in Nonobese Diabetic Mice via Inhibition of Leukocyte Migration Involving the MEK6/p38 and MEK7/JNK Pathways.

Authors:  Ming-Yi Shen; Yu-Ping Lin; Bei-Chang Yang; Yu-Song Jang; Chih-Kang Chiang; Clément Mettling; Zeng-Weng Chen; Joen-Rong Sheu; Cicero L Chang; Yea-Lih Lin; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-13       Impact factor: 2.629

Review 10.  Naturally occurring anthraquinones: chemistry and therapeutic potential in autoimmune diabetes.

Authors:  Shih-Chang Chien; Yueh-Chen Wu; Zeng-Weng Chen; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.